• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. BIOMET BC R 1X40 US; BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. BIOMET BC R 1X40 US; BONE CEMENT Back to Search Results
Catalog Number 110035368
Medical Device Problem Code Loosening of Implant Not Related to Bone-Ingrowth (4002)
Health Effect - Clinical Codes Pain (1994); Swelling/ Edema (4577); Aseptic loosening (4883)
Date of Event 11/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10 - associated medical devices: biomet bc r 1x40 us; item# 110035368; lot# 005dad1508 tibia cemented 5 degree stemmed right size e; item# 42532007102; lot# 64759047 femur cemented cruciate retaining (cr) narrow right size 7; item# 42502006202; lot# 64729467 articular surface medial congruent (mc) right 12 mm height; item# 42522100712; lot# 64427600 all poly patella cemented 32 mm diameter; item# 42540000032; lot# 64775224.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported that the patient underwent an initial right total knee arthroplasty.Approximately two years post-operation, the patient was revised due to pain, swelling, and femoral implant loosening.During the revision surgery, bone loss was noted.The tibial, femoral, and articular surface components were exchanged without complications, and the patella remained implanted.Attempts have been made and no further information has been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMET BC R 1X40 US
Common Device Name
BONE CEMENT
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key25137453
Report Number3006946279-2026-00022
Device Sequence Number9406633
Product Code LOD
UDI-Device Identifier00887868214578
UDI-Public(01)00887868214578(17)241231(10)005DAD1508
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K172408
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 05/11/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date12/31/2024
Device Catalogue Number110035368
Device Lot Number005DAD1508
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/16/2026
Initial Report FDA Received Date05/11/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/17/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11 NARRATIVE.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
-
-